Table 2.
Kaplan-Meier overall survival of enrolled HCC patients.
| Variable | Cases (n=119) | OS (months) Mean ±S.D. | 5-year OS | P value |
|---|---|---|---|---|
| Age (years) | 0.337 | |||
| ≤51.0 | 67 | 41.96±3.76 | 31.2% | |
| >51.0 | 52 | 41.59±4.31 | 40.5% | |
| Gender | 0.708 | |||
| Female | 27 | 39.15±5.12 | 32.6% | |
| Male | 92 | 44.64±3.17 | 36.0% | |
| Tumor number | 0.447 | |||
| Single | 75 | 45.81±3.67 | 40.0% | |
| Multiple | 44 | 55.4±5.7 | 27.8% | |
| Tumor diameter | 0.011* | |||
| ≤5.0 | 50 | 52.01±4.51 | 50.1% | |
| >5.0 | 69 | 37.60±3.18 | 24.8% | |
| TNM stage | 0.021* | |||
| I–II | 46 | 51.30±4.29 | 47.6% | |
| III–IV | 73 | 36.62±2.96 | 26.8% | |
| USP7 expression | 0.030* | |||
| High | 64 | 38.28±3.55 | 29.4% | |
| Low | 55 | 49.40±4.10 | 41.7% |
*
Indicates P<0.05 by log-rank test.